| abstract |
A crystalline form of the antifungal agent (+)-2-(2,4-difluorophenyl)-1-¢3-¢(E)-4-(2,2,3,3-tetrafluoropropoxy)-styryl!-1H-1,2,4-triazol-1-yl!-3- (1H1,2,4-triazol-1-yl)propan-2-ol (code D0870) is described. Furthermore processes for the preparation thereof, to pharmaceutical compositions comprising said crystalline form and to the use thereof in therapy are described. |